Prognostic Value of Age, Subglottic, and Anterior Commissure Involvement for Early Glottic Carcinoma Treated with CO Laser Transoral Microsurgery: a Retrospective, Single-center Cohort Study of 261 Patients
Overview
Authors
Affiliations
Purpose: CO laser transoral microsurgery for glottic carcinoma, when indicated, has the well-established advantages of low morbidity and positive oncological outcomes. The present study aims to determine how patient age, and tumor site could negatively impact prognosis; other variables such as the status of the margins of resection, tobacco and alcohol intake, and the grade of differentiation of the tumors have been evaluated.
Methods: This was a retrospective analysis on 261 patients with a glottic carcinoma who underwent CO laser transoral microsurgery. The impact of different variables was calculated using univariate and multivariate analyses.
Results: The study included 248 males and 13 females. The median follow-up period was 4.3 years. Five-year disease-specific survival, recurrence-free survival, local control with laser alone, overall laryngeal preservation, and overall survival rates were 99.4, 92.2, 93.8, 97.6, and 85.5%, respectively. Equivalent results were observed in young and elderly patients. Patients with positive margins after CO laser transoral microsurgery showed a reduced local control with laser alone. T2 patients with true subglottic spreading and patients with anterior commissure involvement of grade 3 (Rucci's classification) experienced worse local control rates, despite free surgical margins confirmed by histology.
Conclusions: CO laser transoral microsurgery is an effective and reproducible single-stage modality therapy for young and elderly patients with glottic carcinoma. Superficial close margins can be managed by a careful wait-and-see policy, while positive margins should undergo surgical enlargement. In our experience, undifferentiated tumors, true subglottic extension, and anterior commissure involvement of grade 3 were associated with worse outcomes.
Li H, Zhu M, Li M, Chen S, Zhang C, Wang W Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024; 38(10):897-902.
PMID: 39390926 PMC: 11839557. DOI: 10.13201/j.issn.2096-7993.2024.10.003.
Retrospective Analysis of Laryngeal Cancer Patients in a Tertiary Referral Center.
Sungur A, Bayir O, Toptas G, Aksoy S, Karahan S, Yucel V Turk Arch Otorhinolaryngol. 2024; 62(1):21-29.
PMID: 39257046 PMC: 11587523. DOI: 10.4274/tao.2024.2023-12-2.
Doluoglu S, Bayir O, Ocal B, Tatar E, Korkmaz M, Saylam G Ann Saudi Med. 2024; 44(4):213-219.
PMID: 39127898 PMC: 11316948. DOI: 10.5144/0256-4947.2024.213.
Eker C, Surmelioglu O, Dagkiran M, Kaya O, Tanrisever I, Arpaci B Eur Arch Otorhinolaryngol. 2024; 281(5):2597-2608.
PMID: 38424299 PMC: 11023970. DOI: 10.1007/s00405-024-08513-3.
Mariani C, Carta F, Bontempi M, Marrosu V, Tatti M, Pinto V Cancers (Basel). 2023; 15(5).
PMID: 36900281 PMC: 10000552. DOI: 10.3390/cancers15051490.